Surface Oncology, Inc.

Surface Oncology, Inc.verified




Market Cap:


Surface Oncology, Inc., a clinical-stage immuno-oncology company, engages in the development of cancer therapies in the United States. The company develops various antibodies that include NZV930, a fully human immunoglobulin isotype G4 monoclonal antibody for the production of extracellular adenosine; SRF617, a fully human IgG4 monoclonal antibody that inhibits CD39 enzymatic activity for the production of adenosine and the breakdown of adenosine triphosphate; SRF388 targeting interleukin 27; GSK4381562, an antibody targeting CD112R, an inhibitory protein expressed on natural killer and T cells; and SRF114 targeting the chemokine receptor CCR8. Surface Oncology, Inc. has a license agreement ...[Read more]



IPO Date


Stock Exchange




The PE Ratio as of June 2024 (TTM) for Surface Oncology, Inc. (SURF) is -0.69

According to Surface Oncology, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.69. This represents a change of 24.27% compared to the average of -0.55 of the last 4 quarters.

Surface Oncology, Inc. (SURF) Historical PE Ratio (quarterly & annually)

How has SURF PE Ratio performed in the past?

The mean historical PE Ratio of Surface Oncology, Inc. over the last ten years is -4.53. The current -0.69 PE Ratio has changed 1.41% with respect to the historical average. Over the past ten years (40 quarters), SURF's PE Ratio was at its highest in in the March 2022 quarter at 5.91. The PE Ratio was at its lowest in in the June 2017 quarter at -9.80.

Quarterly (TTM)









Surface Oncology, Inc. (SURF) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Surface Oncology, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 126.17%

Maximum Annual PE Ratio = 5.94

Minimum Annual Increase = -701.17%

Minimum Annual PE Ratio = -14.77

Quarterly (TTM)
YearPE RatioChange

Surface Oncology, Inc. (SURF) Average PE Ratio

How has SURF PE Ratio performed in the past?

The current PE Ratio of Surface Oncology, Inc. (SURF) is less than than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg


5-year avg


10-year avg


Surface Oncology, Inc. (SURF) PE Ratio vs. Peers

How is SURF’s PE Ratio compared to its peers?

Surface Oncology, Inc.’s PE Ratio is greater than Syros Pharmaceuticals, Inc. (-1.44), greater than Repare Therapeutics Inc. (-3.36), greater than Personalis, Inc. (-0.69), greater than Evogene Ltd. (-1.55), greater than Iovance Biotherapeutics, Inc. (-4.74),

Build a custom stock screener for Surface Oncology, Inc. (SURF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Surface Oncology, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Surface Oncology, Inc. (SURF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Surface Oncology, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Surface Oncology, Inc.'s PE Ratio?

How is the PE Ratio calculated for Surface Oncology, Inc. (SURF)?

What is the highest PE Ratio for Surface Oncology, Inc. (SURF)?

What is the 3-year average PE Ratio for Surface Oncology, Inc. (SURF)?

What is the 5-year average PE Ratio for Surface Oncology, Inc. (SURF)?

How does the current PE Ratio for Surface Oncology, Inc. (SURF) compare to its historical average?